Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Srikanth, Muppidi"'
Autor:
Richard J. Nowak, Ali A. Habib, Andrew J. Klink, Srikanth Muppidi, Anju Parthan, S. Chloe Sader, Alexandrina Balanean, Ajeet Gajra, James F. Howard, ELEVATE Study Group
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 4, Pp 593-601 (2024)
Abstract Background and Objective The terminal complement inhibitor eculizumab is approved in the USA for the treatment of patients with acetylcholine receptor antibody-positive generalized myasthenia gravis (MG). The ELEVATE study aimed to examine c
Externí odkaz:
https://doaj.org/article/318cee4264874776b6bd5ca2f37e71d9
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
PurposeTo describe the early experience of ravulizumab use in acetylcholine receptor antibody-positive generalized myasthenia gravis (AChR+ve gMG).MethodsThis multicenter retrospective study included AChR+ve gMG patients who were treated with ravuliz
Externí odkaz:
https://doaj.org/article/d2676b2195924eeea1677199cb829f5d
Autor:
Jacqueline Palace, Kristl G Claeys, Andreas Meisel, Casey Quinn, Srikanth Muppidi, Francesco Saccà, Sonia Berrih-Aknin, Mark Larkin, Jon Beauchamp, Sandra Paci, Glenn Philips, Fatemeh Amini, Femke De Ruyck, Joyce Ramirez
Publikováno v:
BMJ Open, Vol 13, Iss 5 (2023)
Objectives This study aims to explore the impact of myasthenia gravis (MG) — in terms of treatments, side effects, comorbidities, psychological health and work or study— in the real world from a patient perspective.Design and participants This is
Externí odkaz:
https://doaj.org/article/1abfca6660ea4b04b7ca9028a4ffc0d7
'This is a very useful board review for the neurophysiology sections in several board certification examinations. Anyone preparing for these examinations should have access to these prototypical questions and the explanations of the answers.'--Doody'
Autor:
Jacqueline Palace, Kristl G Claeys, Renato Mantegazza, Andreas Meisel, Casey Quinn, Srikanth Muppidi, Hiroyuki Murai, Francesco Saccà, Sonia Berrih-Aknin, Sarah Dewilde, Mark Larkin, Jon Beauchamp, Sandra Paci, Laura Day, Glenn Philips, Silvia Chiroli, Guillaume Bassez, MF Janssen
Publikováno v:
BMJ Open, Vol 13, Iss 1 (2023)
Objectives Myasthenia gravis (MG) is a rare, chronic, autoimmune neuromuscular disease which can affect functional and mental aspects of health and health-related quality of life (HRQoL). This study aims to obtain detailed knowledge of the impact of
Externí odkaz:
https://doaj.org/article/89526dac77d5406291833a31dcc90782
Autor:
Nicholas W. Larsen, Lauren E. Stiles, Ruba Shaik, Logan Schneider, Srikanth Muppidi, Cheuk To Tsui, Linda N. Geng, Hector Bonilla, Mitchell G. Miglis
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundAutonomic dysfunction is a known complication of post-acute sequelae of SARS-CoV-2 (PASC)/long COVID, however prevalence and severity are unknown.ObjectiveTo assess the frequency, severity, and risk factors of autonomic dysfunction in PASC,
Externí odkaz:
https://doaj.org/article/8d389b5769184702b2487a7ec36c63d0
Autor:
Srikanth Muppidi, Matthew J Crowley, Brinnae Bent, Peter J Cho, April Wittmann, Connie Thacker, Michael Snyder, Mark Feinglos, Jessilyn P Dunn
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Diabetes prevalence continues to grow and there remains a significant diagnostic gap in one-third of the US population that has pre-diabetes. Innovative, practical strategies to improve monitoring of glycemic health are desperately neede
Externí odkaz:
https://doaj.org/article/ddf3ede38fa540469fa43f66d7630855
Autor:
Richard J. Nowak, Srikanth Muppidi, Said R. Beydoun, Fanny L. O'Brien, Marcus Yountz, James F. Howard
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Introduction: Chronic, broad-spectrum immunosuppressive therapy (IST) can be associated with side effects in many people with generalized myasthenia gravis (gMG), and treatment guidelines recommend that the IST dose be tapered once patients achieve a
Externí odkaz:
https://doaj.org/article/c2c624d8ca5145e090511024f093e78e
Publikováno v:
Journal of Clinical Apheresis.
Autor:
Sandra Tong, Pamela Ventola, Christina H. Frater, Jenna Klotz, Jennifer M. Phillips, Srikanth Muppidi, Selina S. Dwight, William F. Mueller, Brendan J. Beahm, Matt Wilsey, Kevin J. Lee
N-glycanase 1 (NGLY1) Deficiency is a debilitating, ultra-rare autosomal recessive disorder caused by loss of function of NGLY1, a cytosolic enzyme that deglycosylates other proteins. It is characterized by severe global developmental delay and/or in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99b5aaae221e3690d926f49815c1d09f
https://doi.org/10.1101/2023.05.10.23289581
https://doi.org/10.1101/2023.05.10.23289581